Julie L. Engers

Also affiliated with Health Advances (United States), Center for Discovery

Biochemistry, Genetics and Molecular BiologyNeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Discovery of VU0467319: an M1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials”.

Discovery of VU0467319: an M1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials

ACS Chemical Neuroscience(2024)10.1021/acschemneuro.4c00769

N/A

0.457DataRank · unranked

11 citations

Michael R. Wood, Changho Han, Shaun R. Stauffer, Joseph D. Panarese, Bruce J. Melancon +21 more

Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes – Part 2

Bioorganic & Medicinal Chemistry Letters(2021)10.1016/j.bmcl.2021.128416

N/A

0DataRank · unranked

8 citations

Rory A. Capstick, Paul K. Spearing, Julie L. Engers, Alison R. Gregro, Sean R. Bollinger +11 more

The effects of predator odor (TMT) exposure and mGlu3 NAM pretreatment on behavioral and NMDA receptor adaptations in the brain

Neuropharmacology(2022)10.1016/j.neuropharm.2022.108943

N/A

0DataRank · unranked

18 citations

Maya N Bluitt, Julie L. Engers, Craig W. Lindsley, Joyce Besheer, Ryan E. Tyler

Development of a Selective and High Affinity Radioligand, [3H]VU6013720, for the M4 Muscarinic Receptor

Molecular Pharmacology(2023)10.1124/molpharm.122.000643

N/A

0DataRank · unranked

6 citations

Haley E. Kling, Natasha B. Billard, Alice L. Rodriguez, Peng Li, Jonathan W. Dickerson +7 more

Discovery of VU6007496: Challenges in the Development of an M1 Positive Allosteric Modulator Backup Candidate

ACS Chemical Neuroscience(2024)10.1021/acschemneuro.4c00508

N/A

0DataRank · unranked

8 citations

Katrina A. Bollinger, Rory A. Capstick, Madeline F. Long, Aaron M. Bender, Jonathan W. Dickerson +14 more

Discovery of VU6008677: A Structurally Distinct Tricyclic M4 Positive Allosteric Modulator with Improved CYP450 Profile

ACS Medicinal Chemistry Letters(2024)10.1021/acsmedchemlett.4c00249

N/A

0DataRank · unranked

6 citations

Sean R. Bollinger, Julie L. Engers, Madeline F. Long, Sichen Chang, Vincent B. Luscombe +9 more

Computer-Aided Design and Biological Evaluation of Diazaspirocyclic D4R Antagonists

ACS Chemical Neuroscience(2024)10.1021/acschemneuro.4c00086

N/A

0DataRank · unranked

6 citations

Benjamin P. Brown, Daniel Schultz, Julie L. Engers, Valerie M. Kramlinger, Jens Meiler +2 more

Discovery of Thieno[3,2-b]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5

ACS Medicinal Chemistry Letters(2025)10.1021/acsmedchemlett.5c00119

N/A

0DataRank · unranked

2 citations

Scott H. Henderson, Rory A. Capstick, David Whomble, Aaron M. Bender, Andrew S. Felts +18 more

Discovery of the first selective M 4 muscarinic acetylcholine receptor antagonists with in vivo anti-parkinsonian and anti-dystonic efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.12.324152

N/A

0DataRank · unranked

1 citations

Aaron M. Bender, Jonathan W. Dickerson, Daniel J. Foster, Yuping Donsante, Weimin Peng +14 more

Discovery of VU6052254: A Novel, Potent M 1 Positive Allosteric Modulator

ACS Chemical Neuroscience(2025)10.1021/acschemneuro.5c00825

N/A

0DataRank · unranked

0 citations

Joseph D. Bungard, Christopher C. Presley, Irène Zagol-Ikapitte, Katherine J. Watson, Sichen Chang +15 more